What is the first-line treatment for drug-resistant tuberculosis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18611863
Cited by: 0

Abstract

The first-line treatment for drug-resistant tuberculosis primarily includes bedaquiline-based regimens, often in combination with pretomanid, linezolid, or delamanid, to enhance treatment outcome success and safety.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis Antibiotic Resistance in Bacteria

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
29 January 2026
Language
EN